Literature DB >> 19431187

Array-CGH analysis indicates a high prevalence of genomic rearrangements in holoprosencephaly: an updated map of candidate loci.

Claude Bendavid1, Lucie Rochard, Christèle Dubourg, Jonathan Seguin, Isabelle Gicquel, Laurent Pasquier, Jaqueline Vigneron, Annie Laquerrière, Pascale Marcorelles, Corinne Jeanne-Pasquier, Caroline Rouleau, Sylvie Jaillard, Jean Mosser, Sylvie Odent, Veronique David.   

Abstract

Holoprosencephaly (HPE) is the most frequent malformation of the brain. To date, 12 different HPE loci and 8 HPE genes have been identified from recurrent chromosomal rearrangements or from the sequencing of genes from Nodal and SHH pathways. Our cohort of HPE patients presents a high genetic heterogeneity. Point mutations were found in SHH, ZIC2, SIX3, and TGIF genes in about 20% of cases (with 10% in SHH). Deletions in these same genes were found in 7.5% of the patients and 4.4% presented with other subtelomeric gain or losses. Consequently, the molecular basis of HPE remains unknown in 70% of our cohorts. To detect new HPE candidate genes, we used array-CGH to refine the previous karyotype based HPE loci map. We analyzed 111 HPE patients with high-performance Agilent oligonucleotidic arrays and found that 28 presented anomalies involving known or new potential HPE loci located on different chromosomes but with poor redundancy. This study showed an impressive rate of 19 patients among 111 with de novo chromosomal anomalies giving evidence that microrearrangements could be a major molecular mechanism in HPE. Additionally, this study opens new insights on HPE candidate genes identification giving an updated HPE candidate loci map.

Entities:  

Mesh:

Year:  2009        PMID: 19431187     DOI: 10.1002/humu.21016

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

1.  The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes.

Authors:  Aimée D C Paulussen; Constance T Schrander-Stumpel; Demis C J Tserpelis; Matteus K M Spee; Alexander P A Stegmann; Grazia M Mancini; Alice S Brooks; Margriet Collée; Anneke Maat-Kievit; Marleen E H Simon; Yolande van Bever; Irene Stolte-Dijkstra; Wilhelmina S Kerstjens-Frederikse; Johanna C Herkert; Anthonie J van Essen; Klaske D Lichtenbelt; Arie van Haeringen; Mei L Kwee; Augusta M A Lachmeijer; Gita M B Tan-Sindhunata; Merel C van Maarle; Yvonne H J M Arens; Eric E J G L Smeets; Christine E de Die-Smulders; John J M Engelen; Hubertus J Smeets; Jos Herbergs
Journal:  Eur J Hum Genet       Date:  2010-06-09       Impact factor: 4.246

2.  Utilizing prospective sequence analysis of SHH, ZIC2, SIX3 and TGIF in holoprosencephaly probands to describe the parameters limiting the observed frequency of mutant gene×gene interactions.

Authors:  Erich Roessler; Jorge I Vélez; Nan Zhou; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2012-01-12       Impact factor: 4.797

3.  New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases.

Authors:  Sandra Mercier; Christèle Dubourg; Nicolas Garcelon; Boris Campillo-Gimenez; Isabelle Gicquel; Marion Belleguic; Leslie Ratié; Laurent Pasquier; Philippe Loget; Claude Bendavid; Sylvie Jaillard; Lucie Rochard; Chloé Quélin; Valérie Dupé; Véronique David; Sylvie Odent
Journal:  J Med Genet       Date:  2011-09-22       Impact factor: 6.318

4.  Clinical findings in patients with GLI2 mutations--phenotypic variability.

Authors:  C D P Bertolacini; L A Ribeiro-Bicudo; A Petrin; A Richieri-Costa; J C Murray
Journal:  Clin Genet       Date:  2011-01-19       Impact factor: 4.438

Review 5.  Holoprosencephaly: signaling interactions between the brain and the face, the environment and the genes, and the phenotypic variability in animal models and humans.

Authors:  Anna Petryk; Daniel Graf; Ralph Marcucio
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-10-22       Impact factor: 5.814

6.  TGIF Mutations in Human Holoprosencephaly: Correlation between Genotype and Phenotype.

Authors:  A A Keaton; B D Solomon; E F Kauvar; K B El-Jaick; A L Gropman; Y Zafer; J M Meck; S J Bale; D K Grange; B R Haddad; G C Gowans; N J Clegg; M R Delgado; J S Hahn; D E Pineda-Alvarez; F Lacbawan; J I Vélez; E Roessler; M Muenke
Journal:  Mol Syndromol       Date:  2011-05-18

7.  NOTCH, a new signaling pathway implicated in holoprosencephaly.

Authors:  Valérie Dupé; Lucie Rochard; Sandra Mercier; Yann Le Pétillon; Isabelle Gicquel; Claude Bendavid; Georges Bourrouillou; Usha Kini; Christel Thauvin-Robinet; Timothy P Bohan; Sylvie Odent; Christèle Dubourg; Véronique David
Journal:  Hum Mol Genet       Date:  2010-12-31       Impact factor: 6.150

8.  Genomic imbalances detected by array-CGH in patients with syndromal ocular developmental anomalies.

Authors:  Andrée Delahaye; Pierre Bitoun; Séverine Drunat; Marion Gérard-Blanluet; Nicolas Chassaing; Annick Toutain; Alain Verloes; Frédérique Gatelais; Marie Legendre; Laurence Faivre; Sandrine Passemard; Azzedine Aboura; Sophie Kaltenbach; Samuel Quentin; Céline Dupont; Anne-Claude Tabet; Serge Amselem; Jacques Elion; Pierre Gressens; Eva Pipiras; Brigitte Benzacken
Journal:  Eur J Hum Genet       Date:  2012-01-11       Impact factor: 4.246

9.  Pure Distal 7q Duplication: Describing a Macrocephalic Neurodevelopmental Syndrome, Case Report and Review of the Literature.

Authors:  Kerri Bosfield; Jullianne Diaz; Eyby Leon
Journal:  Mol Syndromol       Date:  2021-03-29

10.  Comparison of mutation findings in ZIC2 between microform and classical holoprosencephaly in a Brazilian cohort.

Authors:  Lucilene A Ribeiro; Erich Roessler; Ping Hu; Daniel E Pineda-Alvarez; Nan Zhou; Marypat Jones; Settara Chandrasekharappa; Antonio Richieri-Costa; Maximilian Muenke
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.